These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34242919)

  • 1. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies.
    Ding Z; Wei X; Pan H; Shi H; Shi Y
    Scand J Immunol; 2024 Feb; 99(2):e13344. PubMed ID: 39007954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive Immunity and the Risk of Autoreactivity in COVID-19.
    Moody R; Wilson K; Flanagan KL; Jaworowski A; Plebanski M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines.
    Hromić-Jahjefendić A; Lundstrom K; Adilović M; Aljabali AAA; Tambuwala MM; Serrano-Aroca Á; Uversky VN
    Autoimmun Rev; 2024 Mar; 23(3):103508. PubMed ID: 38160960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: Epitope mimicry as a component cause of autoimmune disease.
    Davies JM
    Cell Mol Life Sci; 2000 Apr; 57(4):523-6. PubMed ID: 11130451
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.
    Karami Fath M; Jahangiri A; Ganji M; Sefid F; Payandeh Z; Hashemi ZS; Pourzardosht N; Hessami A; Mard-Soltani M; Zakeri A; Rahbar MR; Khalili S
    Front Immunol; 2021; 12():705772. PubMed ID: 34447375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Ahmed SBM; Hannawi S; Hamoudi R; Hamid Q; Halwani R
    Front Immunol; 2021; 12():686462. PubMed ID: 34276672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response.
    Routsias JG; Vlachoyiannopoulos PG; Tzioufas AG
    Crit Rev Clin Lab Sci; 2006; 43(3):203-48. PubMed ID: 16574554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mimicry and autoimmunity.
    Rojas M; Restrepo-Jiménez P; Monsalve DM; Pacheco Y; Acosta-Ampudia Y; Ramírez-Santana C; Leung PSC; Ansari AA; Gershwin ME; Anaya JM
    J Autoimmun; 2018 Dec; 95():100-123. PubMed ID: 30509385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mimicry may explain multi-organ damage in COVID-19.
    Angileri F; Legare S; Marino Gammazza A; Conway de Macario E; Jl Macario A; Cappello F
    Autoimmun Rev; 2020 Aug; 19(8):102591. PubMed ID: 32535095
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic mimicry, clonal selection and autoimmunity.
    Cohen IR
    J Autoimmun; 2001 May; 16(3):337-40. PubMed ID: 11334501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
    Vahabi M; Ghazanfari T; Sepehrnia S
    Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens.
    Liang B; Mamula MJ
    Cell Mol Life Sci; 2000 Apr; 57(4):561-8. PubMed ID: 11130456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus-induced autoimmunity.
    Salle V
    Clin Immunol; 2021 May; 226():108694. PubMed ID: 33610741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19.
    Wang JY; Zhang W; Roehrl MW; Roehrl VB; Roehrl MH
    J Autoimmun; 2021 Jun; 120():102644. PubMed ID: 33971585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
    Juanes-Velasco P; Landeira-Viñuela A; García-Vaquero ML; Lecrevisse Q; Herrero R; Ferruelo A; Góngora R; Corrales F; Rivas JL; Lorente JA; Hernández ÁP; Fuentes M
    Front Immunol; 2022; 13():732197. PubMed ID: 35154090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.